Physician

Magdalena U Kowalski, MD

According to 2025 Medicare claims, Magdalena Kowalski, MD (NPI: 1619952686) practices family practice in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Walker, GA. This provider's primary affiliated billing organization is SKIN CANCER & COSMETIC DERMATOLOGY CENTER, PC (NPI: 1376605394; TIN: 58-2441933) and primary practice location at 30736-5178. Kowalski is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Kowalski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 866 traditional Medicare patients, billed 7,429 HCPCS/CPT codes, and received $284,008 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,402 prescription claims across 597 beneficiaries totaling $661,629 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). 2018 DME data shows 27 claims. Open Payments data shows 116 records totaling $2,957. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $13,918 to $284,008. Similarly, Part D prescription costs have risen steadily, from $446,538 to $661,629. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,950 to $611.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	164	1,704	$13,918
2016	150	467	$33,016
2017	368	2,914	$117,107
2018	760	6,374	$332,659
2019	743	7,616	$390,724
2020	838	9,118	$508,075
2021	853	8,929	$467,384
2022	936	9,178	$479,017
2023	918	8,557	$442,119
2024	866	7,429	$284,008

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	396	6,611	$446,538
2016	179	684	$55,076
2017	119	222	$31,347
2018	228	526	$195,591
2019	798	1,823	$474,937
2020	910	2,347	$509,110
2021	692	1,707	$549,208
2022	701	1,662	$632,830
2023	459	1,130	$724,520
2024	597	1,402	$661,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	83	260	$3,624
2016	27	156	$1,627
2017	N/R	43	$598
2018	N/R	27	$558
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	206	231	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	481	605	$60
17000	Destruction of precancer skin growth, 1 growth	486	696	$37
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	420	643	$36
17003	Destruction of precancer skin growth, 2-14 growths	384	2,564	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Unoready Pen	Secukinumab	17	476	$188,385
Cosentyx Sensoready (2 Pens)	Secukinumab	15	392	$111,134
Taltz Autoinjector	Ixekizumab	15	424	$100,247
Dupixent Pen	Dupilumab	17	448	$62,254
Clobetasol Propionate	Clobetasol Propionate	122	3,221	$5,615

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$2,957	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Magdalena U. Kowalski, MD?

Tedicare shows public-source Medicare data for Magdalena U. Kowalski, MD (NPI 1619952686), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Magdalena U. Kowalski, MD have ACO affiliation data?

Magdalena U. Kowalski, MD is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Magdalena U. Kowalski, MD?

Magdalena U. Kowalski, MD is linked to SKIN CANCER & COSMETIC DERMATOLOGY CENTER, PC (billing NPI 1376605394) in the available physician profile data.

Does Magdalena U. Kowalski, MD have Open Payments data?

Magdalena U. Kowalski, MD has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.